Monk Recaps Benefit of Rucaparib Maintenance Therapy in Advanced Ovarian Cancer
Season 7, Episode 15, Jul 18, 2022, 09:06 PM
Dr Monk discusses pertinent efficacy and safety data from the ATHENA-MONO trial, which evaluated first-line maintenance treatment with rucaparib in patients with stage III-IV high-grade ovarian cancer.